Morningstar
•
May 01, 2026
Bio-Rad Laboratories, Inc.: Bio-Rad Earnings: Weakness and Uncertainty in End Markets, Full-Year Guidance Lowered
Summary
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), E
Upgrade to begin using premium research reports and get so much more.
Exclusive reports, detailed company profiles, and best-in-class trade insights to take your portfolio to the next level
UpgradeRelated Reports
Analyst Report: ResMed Inc.
May 01, 2026
•
RMD
Analyst Report: Merck & Co., Inc.
May 01, 2026
•
MRK
Analyst Report: Labcorp Holdings Inc.
Apr 30, 2026
•
LH
Analyst Report: Thermo Fisher Scientific Inc
Apr 30, 2026
•
TMO
Analyst Report: IDEX Corp
Apr 30, 2026
•
IEX

